Press Enter to search · ESC to close

Macro US Stocks

Johnson & Johnson to acquire Ollin Biosciences for up to $3.33B

Johnson & Johnson has agreed to acquire biopharmaceutical company Ollin Biosciences for up to $3.33 billion, the company announced. The deal values Ollin at a headline figure of as much as $3.33 billion, though the structure of the consideration was not immediately detailed. Ollin is a biopharmaceutical company.

Share

Related News

Cointime share card
Long-press image above → Save to Photos / Share
Pitch us Community Feedback